CTOs on the Move

Weill Cornell Medicine

www.weill.cornell.edu

 
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians and scientists in New York City and around the world. The doctors and scientists of Weill Cornell Medicine — faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization—are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side`s scientific corridor, Weill Cornell Medicine`s powerful network of collaborators extends to its parent university Cornell University; to ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Marcos Romero
Information Security Manager Profile
Vipin Kamath
Chief Information Officer Profile
Curtis Cole
Inaugural Vice President and Chief Global Information Officer Profile
Brian Tschinkel
Chief Information Security Officer Profile

Similar Companies

Medical Innovations International

Medical Innovations International is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abkit

Abkit Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Liberty Healthcare Management

Liberty Healthcare Management is a Ramsey, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.

GRO Biosciences

GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.